UK's private obesity drug market choosing Lilly's Mounjaro over Wegovy | REUTERS [k6t62g9dZ4T]
UK's private obesity drug market choosing Lilly's Mounjaro over Wegovy | REUTERS [k6t62g9dZ4T]
| 1h 28m 28s | Video has closed captioning.
Britons paying privately for obesity drugs are increasingly choosing Eli Lilly's Mounjaro over Novo Nordisk's Wegovy, online pharmacies say, in a sign the US drugmaker is gaining ground on its European rival. #News #obesity #britain #Reuters #Newsfeed Read the story here: 👉 Subscribe: Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on Twitter: Follow Reuters on Instagram: #react keto gummies scam #x10 keto boost gummies reviews
Aired: January 06, 2025
Buy Now:
Problems Playing Video? | Closed Captioning